Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 10, Number 7, 1 July 2012

Free Content The impact of blood coagulability on atherosclerosis and cardiovascular disease
pp. 1207-1216(10)
Authors: LOEFFEN, R.; SPRONK, H. M. H.; TEN CATE, H.

Favourites:
ADD

Free Content Aspirin twice a day keeps new COX‐1 at bay
pp. 1217-1219(3)
Authors: LORDKIPANIDZÉ, M.; HARRISON, P.

Favourites:
ADD

Free Content The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes
pp. 1220-1230(11)
Authors: ROCCA, B.; SANTILLI, F.; PITOCCO, D.; MUCCI, L.; PETRUCCI, G.; VITACOLONNA, E.; LATTANZIO, S.; MATTOSCIO, D.; ZACCARDI, F.; LIANI, R.; VAZZANA, N.; DEL PONTE, A.; FERRANTE, E.; MARTINI, F.; CARDILLO, C.; MOROSETTI, R.; MIRABELLA, M.; GHIRLANDA, G.; DAVÌ, G.; PATRONO, C.

Favourites:
ADD

Free Content The CD14++CD16+ monocyte subset and monocyte‐platelet interactions in patients with ST‐elevation myocardial infarction
pp. 1231-1241(11)
Authors: TAPP, L. D.; SHANTSILA, E.; WRIGLEY, B. J.; PAMUKCU, B.; LIP, G. Y. H.

Favourites:
ADD

Free Content Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis
pp. 1242-1251(10)
Authors: RENY, J.‐L.; COMBESCURE, C.; DAALI, Y.; FONTANA, P.; for the PON1 Meta‐Analysis Groupcr5

Favourites:
ADD

Free Content Monocyte‐derived and CD34+/KDR+ endothelial progenitor cells in heart failure
pp. 1252-1261(10)
Authors: SHANTSILA, E.; WRIGLEY, B. J.; SHANTSILA, A.; TAPP, L. D.; GILL, P. S.; LIP, G. Y. H.

Favourites:
ADD

Free Content von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population
pp. 1262-1269(8)
Authors: van LOON, J. E.; KAVOUSI, M.; LEEBEEK, F. W. G.; FELIX, J. F.; HOFMAN, A.; WITTEMAN, J. C. M.; de MAAT, M. P. M.

Favourites:
ADD

Free Content Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose
pp. 1270-1275(6)
Authors: CHEN, C.‐H.; HSIEH, C.‐Y.; LAI, T.‐B.; CHUANG, M.‐T.; CHEN, W.‐L.; SUN, M.‐C.

Favourites:
ADD

Free Content Prognostic clinical prediction rules to identify a low‐risk pulmonary embolism: a systematic review and meta‐analysis
pp. 1276-1290(15)
Authors: SQUIZZATO, A.; DONADINI, M. P.; GALLI, L.; DENTALI, F.; AUJESKY, D.; AGENO, W.

Favourites:
ADD

Free Content Performance of age‐adjusted D‐dimer cut‐off to rule out pulmonary embolism
pp. 1291-1296(6)
Authors: PENALOZA, A.; ROY, P.‐M.; KLINE, J.; VERSCHUREN, F.; LE GAL, G.; QUENTIN‐GEORGET, S.; DELVAU, N.; THYS, F.

Favourites:
ADD

Free Content Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study
pp. 1297-1302(6)
Authors: DENTALI, F.; POLI, D.; SCODITTI, U.; MINNO, M. N. D. DI; STEFANO, V. D.; SIRAGUSA, S.; KOSTAL, M.; PALARETI, G.; SARTORI, M. T.; GRANDONE, E.; VEDOVATI, M. C.; AGENO, W.; for the CEVETIS (CErebral VEin Thrombosis International Study) investigatorscr13

Favourites:
ADD

Free Content A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent
pp. 1303-1311(9)
Authors: VAVALLE, J. P.; RUSCONI, C. P.; ZELENKOFSKE, S.; WARGIN, W. A.; ALEXANDER, J. H.; BECKER, R. C.

Favourites:
ADD

Free Content Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure
pp. 1312-1319(8)
Authors: LISMAN, T.; BAKHTIARI, K.; ADELMEIJER, J.; MEIJERS, J. C. M.; PORTE, R. J.; STRAVITZ, R. T.

Favourites:
ADD

Free Content Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort
pp. 1320-1325(6)
Authors: LYKKE, J. A.; BARE, L. A.; OLSEN, J.; LAGIER, R.; ARELLANO, A. R.; TONG, C.; PAIDAS, M. J.; LANGHOFF‐ROOS, J.

Favourites:
ADD

Free Content Risk‐prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds‐Clot clinical Decision Rule
pp. 1326-1334(9)
Authors: SHARATHKUMAR, A. A.; MAHAJERIN, A.; HEIDT, L.; DOERFER, K.; HEINY, M.; VIK, T.; FALLON, R.; RADEMAKER, A.

Favourites:
ADD
Favourites:
ADD

Free Content Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes
pp. 1342-1351(10)
Authors: ROURKE, C.; CURRY, N.; KHAN, S.; TAYLOR, R.; RAZA, I.; DAVENPORT, R.; STANWORTH, S.; BROHI, K.

Favourites:
ADD

Free Content Making contact with microparticles
pp. 1352-1354(3)
Authors: SHAPIRO, S.; LAFFAN, M.

Favourites:
ADD

Free Content Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa
pp. 1355-1362(8)
Authors: VAN DER MEIJDEN, P. E. J.; VAN SCHILFGAARDE, M.; VAN OERLE, R.; RENNÉ, T.; TEN CATE, H.; SPRONK, H. M. H.

Favourites:
ADD

Free Content Microparticle‐associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients
pp. 1363-1370(8)
Authors: THALER, J.; AY, C.; MACKMAN, N.; BERTINA, R. M.; KAIDER, A.; MAROSI, C.; KEY, N. S.; BARCEL, D. A.; SCHEITHAUER, W.; KORNEK, G.; ZIELINSKI, C.; PABINGER, I.

Favourites:
ADD

Free Content Antidote strategies to reverse anticoagulation with TB‐402, a long‐acting partial inhibitor of factor VIII
pp. 1371-1378(8)
Authors: TANGELDER, M.; LONG, C.; EMMERECHTS, J.; JACQUEMIN, M.; PEERLINCK, K.; VANASSCHE, T.; GLAZER, S.; GIESEN, P.; HOYLAERTS, M.; VERHAMME, P.

Favourites:
ADD
Favourites:
ADD

Free Content Novel aspects of Kindlin‐3 function in humans based on a new case of leukocyte adhesion deficiency III
pp. 1397-1408(12)
Authors: MELLER, J.; MALININ, N. L.; PANIGRAHI, S.; KERR, B. A.; PATIL, A.; MA, Y.; VENKATESWARAN, L.; ROGOZIN, I. B.; MOHANDAS, N.; EHLAYEL, M. S.; PODREZ, E. A.; CHINEN, J.; BYZOVA, T. V.

Favourites:
ADD

Free Content Characterisation of von Willebrand factor A1 domain mutants I1416N and I1416T: correlation of clinical phenotype with flow‐based platelet adhesion
pp. 1409-1416(8)
Authors: McKINNON, T. A. J.; NOWAK, A. A.; CUTLER, J.; RIDDELL, A. F.; LAFFAN, M. A.; MILLAR, C. M.

Favourites:
ADD

Free Content Critical von Willebrand factor A1 domain residues influence type VI collagen binding
pp. 1417-1424(8)
Authors: FLOOD, V. H.; GILL, J. C.; CHRISTOPHERSON, P. A.; BELLISSIMO, D. B.; FRIEDMAN, K. D.; HABERICHTER, S. L.; LENTZ, S. R.; MONTGOMERY, R. R.

Favourites:
ADD

Free Content Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease
pp. 1425-1432(8)
Authors: FLOOD, V. H.; GILL, J. C.; CHRISTOPHERSON, P. A.; WREN, J. S.; FRIEDMAN, K. D.; HABERICHTER, S. L.; HOFFMANN, R. G.; MONTGOMERY, R. R.

Favourites:
ADD

Free Content Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban
pp. 1433-1436(4)
Authors: HARENBERG, J.; MARX, S.; WEISS, C.; KRÄMER, R.; SAMAMA, M.; SCHULMAN, S.; on behalf of the working party: methods to determine rivaroxaban of the Subcommittee on Control of Anticoagulation of the ISTHcr7

Favourites:
ADD

Free Content Association of factor XII gene C46T polymorphism with cerebral venous thrombosis in the south Indian population
pp. 1437-1439(3)
Authors: PRABHAKAR, P.; DE, T.; NAGARAJA, D.; CHRISTOPHER, R.

Favourites:
ADD

Free Content Measurement of anti‐ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays
pp. 1439-1442(4)
Authors: MANCINI, I.; VALSECCHI, C.; PALLA, R.; LOTTA, L. A.; PEYVANDI, F.

Favourites:
ADD

Free Content Platelet factor 4 platelet levels are inversely correlated with steady‐state platelet counts and with platelet transfusion needs in pediatric leukemia patients
pp. 1442-1446(5)
Authors: LAMBERT, M. P.; REZNIKOV, A.; GRUBBS, A.; NGUYEN, Y.; XIAO, L.; APLENC, R.; RAUOVA, L.; PONCZ, M.

Favourites:
ADD

Free Content A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins
pp. 1446-1449(4)
Authors: KELTON, J. G.; WARKENTIN, T. E.; MOORE, J. C.; ARNOLD, D. M.; NAZI, I.; AREPALLY, G. M.; ROACH, J. M.; FIER, I.

Favourites:
ADD

Free Content Biased estimation of thrombosis rates in cancer studies using the method of Kaplan and Meier
pp. 1449-1451(3)
Authors: CAMPIGOTTO, F.; NEUBERG, D.; ZWICKER, J. I.

Favourites:
ADD

Free Content Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage
pp. 1451-1453(3)
Authors: PEYVANDI, F.; BIGUZZI, E.; FRANCHI, F.; BUCCIARELLI, P.; ACAIA, B.; ZAINA, B.; MUSALLAM, K. M.

Favourites:
ADD

Free Content Large infarct and high mortality by cerebral ischemia in mice carrying the factor V Leiden mutation
pp. 1453-1455(3)
Authors: KITA, T.; BANNO, F.; YANAMOTO, H.; NAKAJO, Y.; IIHARA, K.; MIYATA, T.

Favourites:
ADD
Favourites:
ADD

Free Content Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients: a reply to a rebuttal
pp. 1458-1460(3)
Authors: CASTAMAN, G.; BARONCIANI, L.; CANCIANI, M. T.; FEDERICI, A. B.

Favourites:
ADD

Free Content Join ISTH
pp. 1461-1462(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more